Zydus Lifesciences gets USFDA nod for generic medication
News2023-04-24
2 Views
The company has got the final approval from the US Food and Drug Administration (USFDA) to market Icosapent Ethyl Capsules in strength of 0.5 g and 1 g, it said in a regulatory filing.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Breaking News: Crown Equity Holdings, Inc. Appoints New Board Member
